(Q81207686)

English

Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma

scientific article published on 01 April 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

title

Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

William E Osai

1

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

Chaan S Ng

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

Lance C Pagliaro

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

publication date

1 April 2008

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

volume

19

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

page(s)

427-429

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

Identifiers

DOI

10.1097/CAD.0B013E3282F52BEF

1 reference

stated in

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

PubMed ID

18454053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18454053%20AND%20SRC:MED&resulttype=core&format=json

(Q81207686)

Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)